Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Relevance of complement fixing antinuclear antibodies.

Y V Fang1, S J Cyran, B Albini

  • 1Department of Microbiology, State University of New York at Buffalo, 14214, USA.

International Journal of Dermatology
|April 7, 1999
PubMed
Summary

Complement-fixing antinuclear antibodies (C-ANAs) can be present in patients with subacute cutaneous lupus erythematosus (SCLE) or Sjögren's syndrome, even if routine antinuclear antibody (ANA) tests are negative. C-ANA testing aids in diagnosing these connective tissue diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum macromineral dynamics and milk production of old Holstein cows submitted to a postpartum delayed milking strategy.

Veterinary journal (London, England : 1997)·2025
Same author

Does behavioural inhibition system dysfunction contribute to Attention Deficit Hyperactivity Disorder?

Personality neuroscience·2020
Same author

Robust, reproducible, recyclable SERS substrates: monolayers of gold nanostars grafted on glass and coated with a thin silica layer.

Nanotechnology·2018
Same author

Comparison of anger management, anxiety and perceived stress in patients with cancer and Coronary Heart Disease (CHD).

Journal of medicine and life·2017
Same author

Neurofeedback Training as a New Method in Treatment of Crystal Methamphetamine Dependent Patients: A Preliminary Study.

Applied psychophysiology and biofeedback·2015
Same author

Respiratory disorders associated with occupational inhalational exposure to bioaerosols among wastewater treatment workers of petrochemical complexes.

The international journal of occupational and environmental medicine·2015

Area of Science:

  • Rheumatology
  • Immunology
  • Dermatology

Background:

  • Connective tissue diseases (CTDs) encompass a diverse range of disorders characterized by varied clinical symptoms, immunological findings, and frequent syndrome overlaps.
  • Subacute cutaneous lupus erythematosus (SCLE) and Sjögren's syndrome are CTDs often presenting with complex immunological profiles.

Observation:

  • This study investigated eight ANA-negative SCLE cases with anti-Ro (SS-A) antibodies and one complex case exhibiting features of Sjögren's syndrome and systemic lupus erythematosus (SLE).
  • The ninth patient, despite negative serum ANA and C-ANA tests, showed positive in vivo complement fixation to bound ANAs in skin biopsy via C + DIF, alongside antimitochondrial antibodies.

Findings:

  • Five of eight ANA-negative, Ro(SS-A) positive SCLE patients demonstrated C-ANAs in their serum.

Related Experiment Videos

  • The complex case revealed both in vivo and in vitro complement-fixing antinuclear antibodies (C-ANAs), indicating their presence despite initial negative serological markers.
  • Routine serum tests for the complex case identified antimitochondrial antibodies, while normal skin exhibited weak ANA and strong C-ANA reactivity.
  • Implications:

    • Complement-fixing antinuclear antibody (C-ANA) testing can be a valuable tool for diagnosing CTDs, particularly in ANA-negative presentations of SCLE and Sjögren's syndrome.
    • Identifying C-ANAs can improve diagnostic accuracy and potentially guide treatment strategies for patients with overlapping CTD features.
    • These findings highlight the importance of considering C-ANA assays in the diagnostic workup of patients with suspected autoimmune connective tissue diseases who present with atypical serological results.